SynthesisBMC medicine2013

Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.

Tengyue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.